Zhou et al. (2020) reported that one of three dedifferentiated endometrioid carcinomas with neuroendocrine differentiation showed a loss of MSH2/PMS6 expression, which is consistent with our findings. These reports suggest a correlation between MSH2 loss and endometrial dedifferentiated carcinoma. Here, MSH2 is linked to endometrioid adenocarcinoma.